Article
Cost-Effectiveness of Fluorescence In Situ Hybridization in Patients with Atypical Cytology for the Detection of Urothelial Carcinoma
9 Apr 2013
Abstract excerpt
PURPOSE: Patients with atypical cytology and equivocal or negative cystoscopy pose a challenge due to uncertainty about the presence of cancer. We determined the cost-effectiveness of using fluorescence in situ hybridization assays to determine the need for biopsy in patients with atypical cytology and equivocal or negative cystoscopy. MATERIALS AND METHODS: Data from 2 large prospective studies evaluating the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
